OrthoPediatrics Corp. (KIDS)
NASDAQ: KIDS · Real-Time Price · USD
23.76
-0.60 (-2.46%)
Feb 21, 2025, 4:00 PM EST - Market closed
OrthoPediatrics Revenue
OrthoPediatrics had revenue of $54.57M in the quarter ending September 30, 2024, with 36.53% growth. This brings the company's revenue in the last twelve months to $189.67M, up 33.47% year-over-year. In the year 2023, OrthoPediatrics had annual revenue of $148.73M with 21.62% growth.
Revenue (ttm)
$189.67M
Revenue Growth
+33.47%
P/S Ratio
2.88
Revenue / Employee
$767,907
Employees
247
Market Cap
575.37M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 148.73M | 26.44M | 21.62% |
Dec 31, 2022 | 122.29M | 24.24M | 24.72% |
Dec 31, 2021 | 98.05M | 26.97M | 37.95% |
Dec 31, 2020 | 71.08M | -1.47M | -2.03% |
Dec 31, 2019 | 72.55M | 14.99M | 26.05% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
KIDS News
- 3 days ago - OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025 - GlobeNewsWire
- 4 weeks ago - OrthoPediatrics Corp. Announces Distribution Agreement with Thrive Orthopedics LLC - GlobeNewsWire
- 5 weeks ago - OrthoPediatrics Corp. Achieves Record Preliminary Unaudited Revenue for Full Year 2024 and Issues 2025 Financial Guidance - GlobeNewsWire
- 6 weeks ago - OrthoPediatrics Corp. Announces Expansion of Specialty Bracing Division - GlobeNewsWire
- 2 months ago - OrthoPediatrics Corp. Expands Specialty Bracing Portfolio with Two New Products - GlobeNewsWire
- 2 months ago - OrthoPediatrics Corp. to Host Educational and Networking Events at 20th Annual International Pediatric Orthopaedic Symposium (IPOS) - GlobeNewsWire
- 3 months ago - OrthoPediatrics Corp. Expands Specialty Bracing Portfolio with DF2® Brace - GlobeNewsWire
- 3 months ago - OrthoPediatrics Corp. (KIDS) Q3 2024 Earnings Call Transcript - Seeking Alpha